Teal Health Raises $22M Ahead of 2027 Insurance Mandate for At-Home HPV Screening
Image
San Francisco – September 22, 2026 -- Teal Health has closed $22 million in Series A funding to scale its at-home cervical cancer screening device ahead of January 2027, when federal guidelines will require most U.S. health plans to cover self-collection HPV testing.
Funding round brings Teal Health's total capital raised to $45 million
The round was led by .406 Ventures, with continued participation from Emerson Collective (managed by Yosemite), Forerunner, and Serena Ventures, plus new backing from Japan-based MPower Partners. The capital will fund hiring across clinical, commercial, technology and operational teams as the company expands partnerships with payors, health systems, employers and providers.